SGRY
Surgery Partners Inc
NASDAQ · Health Care
$13.56
+0.13 (+0.97%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 3.19B | 2.86B | 226.29M | 225.87M | 203.29M |
| Net Income | -172,386,730 | -138,698,423 | 16.36M | 18.68M | 14.16M |
| EPS | — | — | — | — | — |
| Profit Margin | -5.4% | -5.1% | 7.2% | 8.3% | 7.0% |
| Rev Growth | +11.9% | +11.9% | +12.2% | +15.1% | +17.8% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 572.78M | 572.78M | 642.70M | 801.64M | 805.19M |
| Total Equity | 304.15M | 304.15M | 580.79M | 544.15M | 589.63M |
| D/E Ratio | 1.88 | 1.88 | 1.11 | 1.47 | 1.37 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | 494.20M | 419.71M | 29.95M | 32.99M | 27.67M |
| Free Cash Flow | — | — | 14.68M | 18.84M | 19.47M |